Aceves-Franco, L.A.; Sanchez-Aguilar, O.E.; Barragan-Arias, A.R.; Ponce-Gallegos, M.A.; Navarro-Partida, J.; Santos, A.
The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems. Biomedicines 2023, 11, 1901.
https://doi.org/10.3390/biomedicines11071901
AMA Style
Aceves-Franco LA, Sanchez-Aguilar OE, Barragan-Arias AR, Ponce-Gallegos MA, Navarro-Partida J, Santos A.
The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems. Biomedicines. 2023; 11(7):1901.
https://doi.org/10.3390/biomedicines11071901
Chicago/Turabian Style
Aceves-Franco, Luis Abraham, Oscar Eduardo Sanchez-Aguilar, Allen Rafael Barragan-Arias, Marco Antonio Ponce-Gallegos, Jose Navarro-Partida, and Arturo Santos.
2023. "The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems" Biomedicines 11, no. 7: 1901.
https://doi.org/10.3390/biomedicines11071901
APA Style
Aceves-Franco, L. A., Sanchez-Aguilar, O. E., Barragan-Arias, A. R., Ponce-Gallegos, M. A., Navarro-Partida, J., & Santos, A.
(2023). The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems. Biomedicines, 11(7), 1901.
https://doi.org/10.3390/biomedicines11071901
